National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 71437-71438 [2019-27855]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
Contact Person: Melissa E Nagelin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7202, Bethesda, MD 20892, 301–435–0297,
nagelinmh2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Maximizing the Scientific Value of the
NHLBI Biorepository: Scientific
Opportunities for Exploratory Research.
Date: February 20, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Division of
Extramural Activities, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Rockville, MD 20892, zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Circadian Patterns of Gene Expression
Associated with Disease.
Date: February 28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Division of
Extramural Activities, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Rockville, MD 20892, zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27856 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(D) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Science
Advisory Board for Biosecurity.
The meeting will be open to the
public, with attendance limited to space
available. The meeting will also be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Individuals planning to attend in person
may preregister online at: https://
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
osp.od.nih.gov/biotechnology/nationalscience-advisory-board-for-biosecuritynsabb/. Preregistration will close at
12:00 noon Eastern Time (ET) on
January 17, 2020. Individuals in
attendance may also register onsite on
the day of the meeting. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: January 23–24, 2020.
Time: January 23, 2020, 12:30 p.m. to 5:00
p.m. (ET).
Agenda: The National Science Advisory
Board for Biosecurity will discuss: (1)
Considerations regarding security and public
transparency when sharing information about
research involving enhanced potential
pandemic pathogens; (2) other business of
the Board; and (3) a charge to the committee
will be presented.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: January 24, 2020, 9:00 a.m. (ET) to
Adjournment.
Agenda: The National Science Advisory
Board for Biosecurity will discuss: (1)
Considerations regarding security and public
transparency when sharing information about
research involving enhanced potential
pandemic pathogens; and (2) other business
of the Board.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Shayla Beckham,
Management Program Analyst, Office of
Science Policy, National Institutes of Health,
6705 Rockledge Drive, Suite 750, Bethesda,
MD 20892–9606, 301–496–9838,
shayla.beckham@nih.gov.
Any interested person may file written
comments by forwarding the statement to the
Contact Person listed on this notice.
Additional information about the meeting,
including an agenda, will be posted at:
https://osp.od.nih.gov/biotechnology/
national-science-advisory-board-forbiosecurity-nsabb/ when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: December 19, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27862 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
71437
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel
Transition to Independence SEP, March
10, 2020, 10:30 a.m. to 5:00 p.m.,
National Cancer Institute Shady Grove,
9609 Medical Center Drive, Room
7W602, Rockville, MD 20850
(Telephone Conference Call) which was
published in the Federal Register on
December 16, 2019, 84 FR 68465.
This meeting notice is amended to
correct the meeting name from National
Cancer Institute Special Emphasis Panel
Transition to Independence SEP to
National Cancer Institute Initial Review
Group Transition to Independence. The
meeting is closed to the public.
Dated: December 19, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27854 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Clinical Trials
Review Committee.
Date: February 27–28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn, Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Keary A. Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
E:\FR\FM\27DEN1.SGM
27DEN1
71438
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7190, Bethesda, MD 20892–7924, 301–827–
7912, copeka@mail.nih.gov.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research Review
Committee.
Date: February 27–28, 2020.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892, 301–
827–7992, stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27855 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: January 27, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Allergy, Immunology and Transplantation
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Natcher Building, Conference Room A, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Allergy, Immunology and Transplantation
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room A, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Pages 71437-71438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27855]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
Clinical Trials Review Committee.
Date: February 27-28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn, Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Keary A. Cope, Ph.D., Scientific Review Officer,
Office of Scientific
[[Page 71438]]
Review/DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7190, Bethesda, MD 20892-7924, 301-827-7912,
[email protected].
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Mentored Patient-Oriented Research Review Committee.
Date: February 27-28, 2020.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Stephanie Johnson Webb, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD
20892, 301-827-7992, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: December 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27855 Filed 12-26-19; 8:45 am]
BILLING CODE 4140-01-P
